XBIO · Xenetic Biosciences, Inc.

Summary

Xenetic Biosciences, Inc. filed an 8-K on March 13, 2026, disclosing financial results for the period via Exhibit 99.1 press release under Item 2.02. The filing references historical EPS performance positively beating analyst consensus estimates.

Key takeaways

• Form 8-K filed 2026-03-13
• Item 2.02 Results of Operations
• Exhibit 99.1 Press Release dated 2026-03-13
• Historical EPS: 2026-03-12 $-0.22 vs est $-0.52 (+57.7%)
• 2025-11-12 EPS $-0.33 vs est $-0.49 (+32.7%)
• 2025-08-12 EPS $-0.45 vs est $-0.64 (+29.7%)